Cargando…
Specificity of striatal dopamine D(1) system in humans: implications for clinical use of D(1) receptor-agonists in Parkinson's disease
Autor principal: | Goto, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169585/ https://www.ncbi.nlm.nih.gov/pubmed/37180553 http://dx.doi.org/10.3389/fnhum.2023.1178616 |
Ejemplares similares
-
Mechanisms for the Modulation of Dopamine D(1) Receptor Signaling in Striatal Neurons
por: Nishi, Akinori, et al.
Publicado: (2011) -
Chronic exposure to dopamine agonists affects the integrity of striatal D(2) receptors in Parkinson's patients
por: Politis, Marios, et al.
Publicado: (2017) -
Segregation of D1 and D2 dopamine receptors in the striatal direct and indirect pathways: An historical perspective
por: Gerfen, Charles R.
Publicado: (2023) -
Prevention of Neurite Spine Loss Induced by Dopamine D2 Receptor Overactivation in Striatal Neurons
por: Zheng, Peng, et al.
Publicado: (2020) -
Dopamine-Related Reduction of Semantic Spreading Activation in Patients With Parkinson’s Disease
por: Tiedt, Hannes Ole, et al.
Publicado: (2022)